Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Lindsley

Showing results (451-460 of 570) with videos related to

Pageof 57
Sort By:
Bioorganic & Medicinal Chemistry Letters|September 30, 2017
Discovery of imidazo[1,2-a]-, [1,2,4]triazolo[4,3-a]-, and [1,2,4]triazolo[1,5-a]pyridine-8-carboxamide negative allosteric modulators of metabotropic glutamate receptor subtype 5Andrew S Felts, Alice L Rodriguez, Ryan D Morrison, et al.
Science Translational Medicine|August 18, 2017
mGlu<sub>7</sub> potentiation rescues cognitive, social, and respiratory phenotypes in a mouse model of Rett syndromeRocco G Gogliotti, Rebecca K Senter, Nicole M Fisher, et al.
Bioorganic & Medicinal Chemistry Letters|November 28, 2021
Synthesis and characterization of chiral 6-azaspiro[2.5]octanes as potent and selective antagonists of the M<sub>4</sub> muscarinic acetylcholine receptorAaron M Bender, Trever R Carter, Matthew Spock, et al.
Bioorganic & Medicinal Chemistry Letters|June 28, 2014
Discovery of VU0431316: a negative allosteric modulator of mGlu5 with activity in a mouse model of anxietyBrittney S Bates, Alice L Rodriguez, Andrew S Felts, et al.
Neuropharmacology|June 19, 2012
Potentiation of mGlu5 receptors with the novel enhancer, VU0360172, reduces spontaneous absence seizures in WAG/Rij ratsV D'Amore, I Santolini, C M van Rijn, et al.
Bioorganic & Medicinal Chemistry Letters|October 1, 2013
Discovery of VU0409106: A negative allosteric modulator of mGlu5 with activity in a mouse model of anxietyAndrew S Felts, Alice L Rodriguez, Ryan D Morrison, et al.
The Journal of Biological Chemistry|July 29, 2011
Identification of ML204, a novel potent antagonist that selectively modulates native TRPC4/C5 ion channelsMelissa Miller, Jie Shi, Yingmin Zhu, et al.
ACS Medicinal Chemistry Letters|September 27, 2017
Design and Synthesis of mGlu<sub>2</sub> NAMs with Improved Potency and CNS Penetration Based on a Truncated Picolinamide CoreKatrina A Bollinger, Andrew S Felts, Christopher J Brassard, et al.
Bioorganic & Medicinal Chemistry Letters|May 9, 2006
Synthesis and SAR of novel histamine H3 receptor antagonistsCynthia D Jesudason, Lisa S Beavers, Jeffrey W Cramer, et al.
ACS Chemical Neuroscience|February 18, 2014
Identification of specific ligand-receptor interactions that govern binding and cooperativity of diverse modulators to a common metabotropic glutamate receptor 5 allosteric siteKaren J Gregory, Elizabeth D Nguyen, Chrysa Malosh, et al.
Pageof 57

Showing results (451-460 of 570) with videos related to

Sort By:
Pageof 57
Bioorganic & Medicinal Chemistry Letters|September 30, 2017
Discovery of imidazo[1,2-a]-, [1,2,4]triazolo[4,3-a]-, and [1,2,4]triazolo[1,5-a]pyridine-8-carboxamide negative allosteric modulators of metabotropic glutamate receptor subtype 5Andrew S Felts, Alice L Rodriguez, Ryan D Morrison, et al.
Science Translational Medicine|August 18, 2017
mGlu<sub>7</sub> potentiation rescues cognitive, social, and respiratory phenotypes in a mouse model of Rett syndromeRocco G Gogliotti, Rebecca K Senter, Nicole M Fisher, et al.
Bioorganic & Medicinal Chemistry Letters|November 28, 2021
Synthesis and characterization of chiral 6-azaspiro[2.5]octanes as potent and selective antagonists of the M<sub>4</sub> muscarinic acetylcholine receptorAaron M Bender, Trever R Carter, Matthew Spock, et al.
Bioorganic & Medicinal Chemistry Letters|June 28, 2014
Discovery of VU0431316: a negative allosteric modulator of mGlu5 with activity in a mouse model of anxietyBrittney S Bates, Alice L Rodriguez, Andrew S Felts, et al.
Neuropharmacology|June 19, 2012
Potentiation of mGlu5 receptors with the novel enhancer, VU0360172, reduces spontaneous absence seizures in WAG/Rij ratsV D'Amore, I Santolini, C M van Rijn, et al.
Bioorganic & Medicinal Chemistry Letters|October 1, 2013
Discovery of VU0409106: A negative allosteric modulator of mGlu5 with activity in a mouse model of anxietyAndrew S Felts, Alice L Rodriguez, Ryan D Morrison, et al.
The Journal of Biological Chemistry|July 29, 2011
Identification of ML204, a novel potent antagonist that selectively modulates native TRPC4/C5 ion channelsMelissa Miller, Jie Shi, Yingmin Zhu, et al.
ACS Medicinal Chemistry Letters|September 27, 2017
Design and Synthesis of mGlu<sub>2</sub> NAMs with Improved Potency and CNS Penetration Based on a Truncated Picolinamide CoreKatrina A Bollinger, Andrew S Felts, Christopher J Brassard, et al.
Bioorganic & Medicinal Chemistry Letters|May 9, 2006
Synthesis and SAR of novel histamine H3 receptor antagonistsCynthia D Jesudason, Lisa S Beavers, Jeffrey W Cramer, et al.
ACS Chemical Neuroscience|February 18, 2014
Identification of specific ligand-receptor interactions that govern binding and cooperativity of diverse modulators to a common metabotropic glutamate receptor 5 allosteric siteKaren J Gregory, Elizabeth D Nguyen, Chrysa Malosh, et al.
Pageof 57